Teknova Q3 Revenue Tops Estimates at $12.7M, FY Outlook In Line
TKNO has more than doubled off its 52-week low of $1.91.
Summary
Teknova reported Q3 revenue of $12.704 million against an IBES estimate of $11.6 million, a clear beat, with gross profit of $4.826 million and a net loss of $3.49 million, or -$0.06 per share. The FY revenue outlook of $46-48 million brackets the $46.1 million consensus, so guidance is essentially in line rather than a raise. This is the first hard numbers on the quarter after the October 20 pre-announcement, which only gave a $12.5-12.7 million revenue range and 36-38% gross margin — the actual top line landed at the high end of that range. The stock trades near $7.37, well above the $5.00 price of the $40 million offering priced October 21, so the dilution overhang has been absorbed.
At the time of this announcement, TKNO was trading at $7.37 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $454.7M. The 52-week trading range was $1.91 to $9.48. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.